Top Back to top

Autologous Stem Cell Transplantation International Crohn's Disease Trial: a multicentre, prospective, randomised phase II study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

Autoimmune Diseases Working Party (ADWP)
Study number:
2005-003337-40
Type of transplant:
 
Short title:
ASTIC
Study status:
Follow-up
Deadline for data collection:
 
Study design:
Open label, randomised multicentre study
Primary objective:
To evaluate the potential clinical benefit of hematopietic stem cell mobilisation by high dose immunoablation and autologous stem cell transplantation versus hematopoietic stem cell mobilisation only followed by best clinical practice in patients with Crohn's disease
Key inclusion criteria:
18-50 years old
Country:
United Kingdom
France
Czech Republic
Germany
Italy
Spain
Switzerland
Canada
Principal investigator:
Christopher J Hawkey
Principal investigator email:
 
EBMT Study coordinator:
Janette Zarev